1) vasorelaxant activity
血管舒张活性
1.
Design,synthesis and vasorelaxant activity of R,S-1-(substituted phenyl)-4-[3-(naphtha-1-yl-oxy)-2-hydroxypropyl]-piperazine derivatives;
R,S-1-(取代苯基)-4-[3-(萘-1-氧基)-2-羟基丙基]哌嗪类化合物的设计、合成及血管舒张活性
2.
The compounds were tested for their vasorelaxant activity in low (30 mmo.
离体扩血管活性实验表明 ,大部分化合物具有一定的血管舒张活性。
2) vascular relaxing activity
舒张血管活性
1.
Synthesis and vascular relaxing activity of new arecoline analogues containing 1,2,4-triazole sulfanylether;
含均三唑硫醚的槟榔碱衍生物的合成及舒张血管活性
3) vasorelaxation
血管舒张
1.
The vessel tension was investigated to study the vasorelaxation effect of F.
方法：建立大鼠在体I／R模型、后期预适应(LPC)模型，测定心肌保护的血清学和组织学指标，观察FLNT对I／R损伤的治疗作用和LPC预防性保护作用；建立血管张力体外模型观察FLNT对KCl、去甲肾上腺素和乙酰胆碱等预收缩的外周血管和冠脉血管舒张作用；运用鸟苷酸环化酶(GC)和钾通道的阻断剂预孵育血管和膀胱平滑肌，观察FLNT对GC酶和钾通道的作用；对FLNT代谢后血清和尿液样品进行HPLC-MS-MS分析，观察FLNT的主要代谢途径，并对其主要代谢物进行抗心肌I／R损伤和血管舒张的活性研究。
2.
K~+ channel blockers did not reversed vasorelaxation indu
本实验旨在观察没食子酸丙酯对离体大鼠胸主动脉环的血管舒张作用,并对其可能的作用机制进行初步探讨。
3.
The vasorelaxation induced by MS23 is related neither to endothelium nor to nitric oxide synthesis.
去内皮和一氧化氮合酶抑制剂L-NAME对MS23的血管舒张作用无明显影响。
4) Vasodilation
[英][,veizəudai'leiʃən] [美][,vezodaɪ'leʃən, -dɪ-]
血管舒张
1.
The relationship between arterial elasticity and impaired vasodilation in patients with coronary artery disease;
冠心病患者动脉弹性与血管舒张功能受损的关系
2.
Content analyses of polysaccharides, alkaloids and mineral elements from Dendrobium hancockii and vasodilation activity of its water-soluble extraction;
细叶石斛有效成分分析及其水溶性提取物的血管舒张活性
3.
Effect of Orlistat on Endothelium-Dependent Vasodilation in Overweight Patients With Hypertension;
奥利司他对超重合并高血压患者内皮依赖性血管舒张功能的影响
5) vasodilatation
[英][,væsəu,dilə'teiʃən] [美][væso,dɪlə'teʃən]
血管舒张
1.
Influence of estrogen on vasodilatation of perimenopausal women;
雌激素对围绝经期女性血管舒张功能的影响
2.
Objective To study the role of cAMP-PKA signal transduction pathway on vasodilatation of rat aortic rings caused by SO2 derivatives.
结论SO2衍生物可使PGI2-cAMP-PKA信号通路活化,这可能是SO2导致血管舒张的机制之一。
3.
Objective To investigate the functional features of resveratrol on vasodilatation of abdominal aorta in rat and its underlying mechanism.
05);在阿托品组,普萘洛尔组,消炎痛组中,血管舒张的受抑制程度与对照组差别无显著性(P>0。
6) Vasorelaxant
舒张血管
1.
Progress of Vasorelaxant Substances from Natural Products;
天然舒张血管活性物质研究进展
补充资料：舒张
舒张
肌肉的张力和长度恢复到收缩前状态的过程。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条